More than 170 million people worldwide are chronically infected with the hepatitis C virus
(HCV), which is responsible for over 1 million deaths resulting from cirrhosis and liver …

Abstract In 2016, the Transplantation Society of Australia and New Zealand, with the support
of the Australian Government Organ and Tissue authority, commissioned a literature review …

• Using factors known to be associated with an increased likelihood of recent HIV, HBV, or
HCV infection to identify potential donors who may be at increased risk for transmitting …

Kidney transplantation from hepatitis C virus (HCV) antibody positive donors (HCVD+) into
HCV antibody positive recipients (HCVR+) is controversial. We implemented this policy in …

Hepatitis C virus (HCV) causes chronic systemic infection, primarily affecting the liver.
Although HCV mainly causes hepatitis, a significant portion of chronic HCV patients …

A debate exists about informing potential organ-transplant recipients about the general risks
associated with transplantation and the specific risks associated with a particular organ. In …

Die Überarbeitung der 2004 publizierten S3-Leitlinie über „Prophylaxe, Diagnostik und
Therapie der Hepatitis-C-Virus (HCV)-Infektion “wurde vereinbart als Kooperation der …

Chronic kidney disease (CKD) has become a major public health problem worldwide over
the past few decades because of the increasing prevalence of hypertension, diabetes …

The Organ Procurement and Transplantation Network database (2001–2006) was reviewed
for kidney transplant (KT) recipients, to evaluate the effects of use of grafts from donors …

BACKGROUND: Hepatitis C (HCV) is among the most common causes of end-stage liver
disease worldwide. The donor shortage leads us to consider alternative organ sources such …